Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
Pagel
John M
JM
Lionberger
Jack
J
Gopal
Ajay K
AK
Sabath
Daniel E
DE
Loeb
Keith
K
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D015618:Histiocytosis, Sinus / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab